MediPharm Labs (TSE:LABS) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MediPharm Labs is selling its Napanee facility to Kensana Health for $5.5 million, forming a strategic partnership to enhance their manufacturing capabilities and support future growth. This move aligns with MediPharm’s strategy to streamline operations and maximize stakeholder value, while Kensana aims to advance its phytopharmaceutical development. The deal is expected to close by January 1, 2025.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.